title: The response of neurons in the bed nucleus of the stria terminalis to serotonin: implications for anxiety.
abstract: Substantial evidence has suggested that the activity of the bed nucleus of the stria terminalis (BNST) mediates many forms of anxiety-like behavior in human and non-human animals. These data have led many investigators to suggest that abnormal processing within this nucleus may underlie anxiety disorders in humans, and effective anxiety treatments may restore normal BNST functioning. Currently some of the most effective treatments for anxiety disorders are drugs that modulate serotonin (5-HT) systems, and several decades of research have suggested that the activation of 5-HT can modulate anxiety-like behavior. Despite these facts, relatively few studies have examined how activity within the BNST is modulated by 5-HT. Here we review our own investigations using in vitro whole-cell patch-clamp electrophysiological methods on brain sections containing the BNST to determine the response of BNST neurons to exogenous 5-HT application. Our data suggest that the response of BNST neurons to 5-HT is complex, displaying both inhibitory and excitatory components, which are mediated by 5-HT(1A), 5-HT(2A), 5-HT(2C) and 5-HT(7) receptors. Moreover, we have shown that the selective activation of the inhibitory response to 5-HT reduces anxiety-like behavior, and we describe data suggesting that the activation of the excitatory response to 5-HT may be anxiogenic. We propose that in the normal state, the function of 5-HT is to dampen activity within the BNST (and consequent anxiety-like behavior) during exposure to threatening stimuli; however, we suggest that changes in the balance of the function of BNST 5-HT receptor subtypes could alter the response of BNST neurons to favor excitation and produce a pathological state of increased anxiety.
authors.affiliation: Department of Psychology, University of Vermont, 2 Colchester Avenue, John Dewey Hall, Burlington, VT 05405, USA. shammack@uvm.edu
authors.forename: Sayamwong E
authors.initials: SE
authors.lastname: Hammack
authors.forename: Ji-Dong
authors.initials: JD
authors.lastname: Guo
authors.forename: Rimi
authors.initials: R
authors.lastname: Hazra
authors.forename: Joanna
authors.initials: J
authors.lastname: Dabrowska
authors.forename: Karyn M
authors.initials: KM
authors.lastname: Myers
authors.forename: Donald G
authors.initials: DG
authors.lastname: Rainnie
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001008:Anxiety Disorders / Q000378:metabolism / Q000473:pathology*; D004195:Disease Models, Animal; D006801:Humans; D066298:In Vitro Techniques; D009474:Neurons / Q000187:drug effects*; D018408:Patch-Clamp Techniques; D017729:Presynaptic Terminals / Q000502:physiology; D011903:Raphe Nuclei / Q000378:metabolism; D011985:Receptors, Serotonin / Q000502:physiology; D012686:Septal Nuclei / Q000166:cytology*; D012701:Serotonin / Q000494:pharmacology*; D018490:Serotonin Agents / Q000494:pharmacology*
chemical_list: D011985:Receptors, Serotonin; D018490:Serotonin Agents; D012701:Serotonin